Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 15, 2008, 10.1148/radiol.2482071578
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2482071578v1
248/3/876    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Ogawa, H.
Right arrow Articles by Naganawa, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogawa, H.
Right arrow Articles by Naganawa, S.
(Radiology 2008;248:876-886.)
© RSNA, 2008


Gastrointestinal Imaging

Intraductal Papillary Mucinous Neoplasm of the Pancreas: Assessment of the Likelihood of Invasiveness with Multisection CT1

Hiroshi Ogawa, MD, Shigeki Itoh, MD, Mitsuru Ikeda, MD, Kojiro Suzuki, MD, and Shinji Naganawa, MD

1 From the Department of Radiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan (H.O., K.S., S.N.); and Department of Technical Radiology, Nagoya University School of Health Sciences, Nagoya, Japan (S.I., M.I.). Received September 5, 2007; revision requested November 16; revision received December 6; accepted February 26, 2008; final version accepted March 5. Address correspondence to H.O. (e-mail: g050609d{at}mbox.nagoya-u.ac.jp).

Purpose: To evaluate the capabilities of multisection computed tomography (CT) in determining the likelihood of invasiveness of intraductal papillary mucinous neoplasm (IPMN).

Materials and Methods: The institutional review board approved this research and waived informed consent from the patients. Two radiologists blinded to the pathologic assessment of malignancy or parenchymal invasion of IPMN retrospectively evaluated CT images of 61 consecutive surgically resected tumors (26 adenomas, 15 noninvasive carcinomas, and 20 invasive carcinomas) in patients who underwent multiphase contrast material–enhanced CT with 0.5- or 1-mm collimation. The findings were statistically analyzed by using univariate and multivariate analyses, with the optimal cutoff levels of each continuous parameter determined by generating receiver operating characteristic curves.

Results: The following findings showed significant differences among the three groups: maximum diameter of the main pancreatic duct (MPD), size (length of major axis) of the largest mural nodule in the MPD or in any associated cystic lesion, abnormal attenuating area in the surrounding parenchyma, calcification in the lesion, protrusion of the MPD into the ampulla of Vater, and bile duct dilatation. An MPD diameter of 6 mm or larger, a mural nodule of 3 mm or larger, and an abnormal attenuating area were independently predictive of malignancy. A mural nodule of 6.3 mm or larger in the MPD and an abnormal attenuating area were independently predictive of parenchymal invasion. According to these criteria, the sensitivity, specificity, and accuracy for identifying malignancy were 83%, 81%, and 82% and for identifying parenchymal invasion were 90%, 88%, and 89%, respectively.

Conclusion: Multisection CT is useful for distinguishing among adenoma, noninvasive carcinoma, and invasive carcinoma in patients with IPMN.

© RSNA, 2008







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2008 by the Radiological Society of North America.